Uniplan Investment Counsel’s Dynavax Technologies DVAX Stock Holding History

Uniplan Investment Counsel’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-181,429	Closed	-$2.79M	–	192
2025 Q4	$2.79M	Buy	181,429 +54,190	+43%	+$597K	0.28%	98
2025 Q3	$1.26M	Sell	127,239 -20,907	-14%	-$218K	0.12%	139
2025 Q2	$1.47M	Buy	148,146 +111,561	+305%	+$1.18M	0.15%	117
2025 Q1	$475K	Buy	+36,585	New	+$484K	0.05%	135

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Uniplan Investment Counsel's DVAX Position: Q1 2026 in Review

Uniplan Investment Counsel sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 181,429 shares — an estimated $2.79M sold.

Uniplan Investment Counsel first reported a position in DVAX in Q1 2025 and held it in 4 quarters. The position peaked at $2.79M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Uniplan Investment Counsel reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Uniplan Investment Counsel sold 181,429 Dynavax Technologies shares in Q1 2026, an estimated $2.79M.
Uniplan Investment Counsel first reported a position in Dynavax Technologies in Q1 2025 and held it in 4 quarters.
Uniplan Investment Counsel's Dynavax Technologies position peaked at $2.79M in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.